FGFR1 and neoplasm: Preclinical data have demonstrated that the FGF/FGFR1 axis is a key mediator of angiogenesis [10,11] and PCa dissemination [10,11], whereas targeting this pathway inhibited both tumor growth and blood vessel formation [12].